Amoxylac Tablet DT
In Treatment of Bacterial infections Amoxylac Tablet DT is a medicine given to children for the treatment of a wide range of bacterial infections. These infections may include otitis media (ear infection), sinusitis (sinus infection), tonsillitis (infection of tonsils), dental abscess (tooth infection), pneumonia (lung infection), cellulitis (skin infection), and urinary tract infection. The presence of probiotics reduces the chance of side effects like stomach upset or diarrhea in your child which may occur due to the prolonged intake of antibiotics.u003cbr>u003cbr>Amoxylac Tablet DT is also given for several infections that are suspected to be caused by the bacteria but the type of bacteria is not known (empirical therapy). Usually, children start to feel better within 2-3 days of regular dosing. Make sure to finish the recommended course of the medicine as stopping the medicine abruptly may lead to ineffective treatment or worsen your child’s condition.
Amoxylan Oral Suspension
In Treatment of Resistance Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Amoxylan Oral Suspension comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.
Amoxylat 625 Tablet
In Bacterial infections Amoxylat 625 Tablet is a medicine that helps to kill the bacteria that cause infections. This combination medicine can be used to treat many different bacterial infections. It causes loss of the useful bacteria that are present naturally in our body. It contains probiotics that help restore the useful bacteria, improve digestion and enhance overall health. Amoxylat 625 Tablet usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Amoxylav CV Dry Syrup
In Treatment of Resistance Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Amoxylav CV Dry Syrup comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.
Amoxylav-DS Dry Syrup
In Treatment of Resistant Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Amoxylav-DS Dry Syrup comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.
Amoxylead 625 Tablet
In Treatment of Bacterial infections Amoxylead 625 Tablet contains two medicines, Amoxycillin and Clavulanic Acid, that work together to kill the bacteria that cause infections. Amoxycillin works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Amoxycillin against bacteria.u003cbr>Amoxylead 625 Tablet can treat many bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to ensure all bacteria are killed and do not become resistant.
Amoxylet CV 500mg/125mg Tablet
In Treatment of Bacterial infections Amoxylet CV 500mg/125mg Tablet contains two medicines, Amoxycillin and Clavulanic Acid, that work together to kill the bacteria that cause infections. Amoxycillin works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Amoxycillin against bacteria.u003cbr>Amoxylet CV 500mg/125mg Tablet can treat many bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to ensure all bacteria are killed and do not become resistant.
Amoxylet CV Oral Suspension
In Treatment of Resistance Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Amoxylet CV Oral Suspension comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.
Amoxylet LB Tablet
In Treatment of Bacterial infections Amoxylet LB Tablet is used to treat and control different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin. It works by killing the bacteria causing infections in the body. Make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Amoxylic Dry Syrup
In Treatment of Resistance Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Amoxylic Dry Syrup comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.
Amoxylimb CV Dry Syrup
In Treatment of Resistance Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Amoxylimb CV Dry Syrup comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.
Amoxylimb Dry Syrup
In Treatment of Resistant Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Amoxylimb Dry Syrup comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.